| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |